Ignite Creation Date:
2025-12-24 @ 11:17 PM
Ignite Modification Date:
2025-12-25 @ 8:55 PM
Study NCT ID:
NCT00309556
Status:
COMPLETED
Last Update Posted:
2011-12-30
First Post:
2006-03-31
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer
Sponsor:
Austrian Breast & Colorectal Cancer Study Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-02
Start Date Type:
None
Primary Completion Date:
2009-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-11
Completion Date Type:
ACTUAL
First Submit Date:
2006-03-31
First Submit QC Date:
None
Study First Post Date:
2006-04-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-12-29
Last Update Post Date:
2011-12-30
Last Update Post Date Type:
ESTIMATED